{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:11:41Z","timestamp":1789035101231,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Breast reconstruction after mastectomy or breast-conserving surgery requires careful planning that accounts for patient preference, comorbidities, tumor characteristics, and anticipated neoadjuvant or adjuvant therapies. Advances in the treatment of breast cancer have led to evolving recommendations for these therapies, with each influencing not just the complications from surgery but also the long-term outcomes. This narrative review summarizes the current indications for these therapies and their potential impacts on breast reconstruction. Contemporary recommendations for postmastectomy radiation therapy, chemotherapy, immunotherapy, endocrine therapy, and other targeted therapies are explored, with an emphasis placed on perioperative management of systemic therapies and how they may influence reconstructive decision-making. Understanding the nuances of these therapies enables plastic surgeons to be strategic in the timing of reconstruction through individualized planning and can improve reconstructive success. As breast cancer treatment evolves, familiarity with oncologic management is essential for achieving safe, patient-centered care.<\/jats:p>","DOI":"10.3390\/jcm15187000","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:13:03Z","timestamp":1789031583000},"page":"7000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Therapies for Breast Cancer: What the Plastic Surgeon Needs to Know"],"prefix":"10.3390","volume":"15","author":[{"given":"Erin","family":"Jadallah","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"McConaghy","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3517-1523","authenticated-orcid":false,"given":"Min-Jeong","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bjps.2023.04.007","article-title":"The effect of chemotherapy on the complication rates of breast reconstruction: A systematic review and meta-analysis","volume":"82","author":"Seth","year":"2023","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e5915","DOI":"10.1097\/GOX.0000000000005915","article-title":"Breast cancer immunotherapy: A clinical review for the plastic surgeon","volume":"12","author":"Heron","year":"2024","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.1097\/PRS.0000000000003943","article-title":"Breast reconstruction and radiation therapy: An update","volume":"140","author":"Nelson","year":"2017","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1200\/JCO-25-01747","article-title":"Postmastectomy radiation therapy: An ASTRO-ASCO-SSO clinical practice guideline","volume":"43","author":"Jimenez","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2016.69.1188","article-title":"Postmastectomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update","volume":"34","author":"Recht","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/PRS.0000000000012309","article-title":"Evaluation of breast volume following lumpectomy combined with oncoplastic reduction mammaplasty and radiation therapy","volume":"157","author":"Harfouche","year":"2026","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/PRS.0000000000000523","article-title":"The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: An analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years","volume":"134","author":"Cordeiro","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bjps.2017.05.057","article-title":"Determining the outcomes of post-mastectomy radiation therapy delivered to the definitive implant in patients undergoing one- and two-stage implant-based breast reconstruction: A systematic review and meta-analysis","volume":"70","author":"Magill","year":"2017","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0040-1716846","article-title":"A meta-analysis of autologous microsurgical breast reconstruction and timing of adjuvant radiation therapy","volume":"37","author":"Heiman","year":"2021","journal-title":"J. Reconstr. Microsurg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1016\/j.bjps.2021.08.005","article-title":"Does post-mastectomy radiation therapy worsen outcomes in immediate autologous breast flap reconstruction? A systematic review and meta-analysis","volume":"74","author":"Liew","year":"2021","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0042-1750125","article-title":"Optimal timing of delayed microvascular breast reconstruction after radiation therapy","volume":"39","author":"Arnautovic","year":"2023","journal-title":"J. Reconstr. Microsurg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e31091","DOI":"10.1002\/micr.31091","article-title":"The impact of post-mastectomy radiation timing on overall outcomes of autologous free-flap breast reconstruction","volume":"44","author":"Parmeshwar","year":"2024","journal-title":"Microsurgery"},{"key":"ref_14","unstructured":"Cancer Research UK (2026, July 02). TNM Staging for Breast Cancer. Available online: https:\/\/www.cancerresearchuk.org\/about-cancer\/breast-cancer\/stages-grades\/tnm-staging#tumour-(t)."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40291-020-00482-7","article-title":"Oncotype DX breast recurrence score: A review of its use in early-stage breast cancer","volume":"24","author":"Syed","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","article-title":"Overview of breast cancer therapy","volume":"13","author":"Moo","year":"2018","journal-title":"PET Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/gs.2016.08.06","article-title":"Time interval of neoadjuvant chemotherapy to surgery in breast cancer: How long is acceptable?","volume":"6","author":"Yoo","year":"2017","journal-title":"Gland Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1245\/s10434-020-09177-z","article-title":"Adjuvant chemotherapy in two-stage tissue expander\/implant breast reconstruction: Does it affect final outcomes?","volume":"28","author":"Lee","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.suc.2022.08.017","article-title":"Preoperative systemic therapy for breast cancer","volume":"103","author":"Kodali","year":"2023","journal-title":"Surg. Clin. N. Am."},{"key":"ref_22","unstructured":"American Society of Breast Surgeons (2026, July 02). Resource Guide: Preoperative Management of Patients Treated with Neoadjuvant Systemic Therapy. Available online: https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-rg-nst.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/PRS.0000000000008505","article-title":"Comparison of autologous breast reconstruction complications by type of neoadjuvant chemotherapy regimen","volume":"148","author":"Olawoyin","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clbc.2023.12.004","article-title":"Effects of neoadjuvant chemotherapy on autologous and implant-based breast reconstruction: A systematic review and meta-analysis","volume":"24","author":"Nag","year":"2024","journal-title":"Clin. Breast Cancer"},{"key":"ref_25","unstructured":"U.S. Food and Drug Administration (2026, July 02). Herceptin (Trastuzumab) Prescribing Information, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/103792s5354lbl.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Galuia, M., Fedorova, J., McHayleh, W., Mamounas, E., Ahmad, S., and Pavri, S. (2025). Perioperative drug management of systemic therapies in breast cancer: A literature review and treatment recommendations. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32030154"},{"key":"ref_27","unstructured":"U.S. Food and Drug Administration (2025). Kisqali (Ribociclib) Tablets, Prescribing Information."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/cncr.34367","article-title":"Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer","volume":"128","author":"Watson","year":"2022","journal-title":"Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dvir, K., Giordano, S., and Leone, J.P. (2024). Immunotherapy in breast cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147517"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clbc.2025.03.004","article-title":"Perioperative considerations of breast cancer neoadjuvant treatments","volume":"25","author":"Brumer","year":"2025","journal-title":"Clin. Breast Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.bjps.2017.05.046","article-title":"Impact of adjuvant anti-estrogen therapies on perioperative outcomes of breast reconstruction","volume":"70","author":"Billon","year":"2017","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.mayocp.2020.10.002","article-title":"SPAQI consensus statement on perioperative medication management","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-022-06558-8","article-title":"Safe perioperative tamoxifen use in autologous breast free flap reconstruction: Systematic review and meta-analysis","volume":"193","author":"Webster","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e31823ae86c","article-title":"Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction","volume":"129","author":"Kelley","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/SAP.0000000000002394","article-title":"Perioperative use of antiestrogen therapies in breast reconstruction: A systematic review and treatment recommendations","volume":"85","author":"Spera","year":"2020","journal-title":"Ann. Plast. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e6868","DOI":"10.1097\/GOX.0000000000006868","article-title":"The Impact of Hormonal Therapy on Autologous Microvascular Breast Reconstruction: A Systematic Review and Meta-analysis","volume":"13","author":"Verbat","year":"2025","journal-title":"Plast. Reconstr. Surg. Glob. Open"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7000\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:42:59Z","timestamp":1789033379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":37,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187000"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187000","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}